Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang Cheng

Showing results (1091-1100 of 1,102) with videos related to

Pageof 111
Sort By:
Current Medical Research and Opinion|April 20, 2018
Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort studyZhi-Hong Liu, Xue-Qing Yu, Jun-Wei Yang, et al.
Cancers|February 11, 2023
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaHsueh-Chien Chiang, Yang-Cheng Lee, Ting-Tsung Chang, et al.
Nature Materials|September 15, 2022
Designed growth of large bilayer graphene with arbitrary twist anglesCan Liu, Zehui Li, Ruixi Qiao, et al.
Immunity|July 16, 2021
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinomaYang Cheng, Bavani Gunasegaran, Harsimran D Singh, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 11, 2023
Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in TaiwanMing-Ching Shen, Sheng-Chieh Chou, Shyh-Shin Chiou, et al.
Journal of Medicinal Chemistry|September 11, 2024
Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 MutationsTian-Hua Wei, Zi-Xuan Wang, Meng-Yi Lu, et al.
Cancer Discovery|September 14, 2023
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform TrialTina Cascone, Gozde Kar, Jonathan D Spicer, et al.
Bioorganic & Medicinal Chemistry|July 21, 2022
Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemiaJi-Bo Kang, Lu Chen, Xue-Jiao Leng, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 26, 2019
Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention of Recurrent Cardiovascular Events in a Real-World Cohort of Post-Acute Myocardial Infarction PatientsDuo Huang, Yang-Yang Cheng, Yiu-Tung Anthony Wong, et al.
ERJ Open Research|March 14, 2018
Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) studyDuo Huang, Yang-Yang Cheng, Pak-Hei Chan, et al.
Pageof 111

Showing results (1091-1100 of 1,102) with videos related to

Sort By:
Pageof 111
Current Medical Research and Opinion|April 20, 2018
Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort studyZhi-Hong Liu, Xue-Qing Yu, Jun-Wei Yang, et al.
Cancers|February 11, 2023
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaHsueh-Chien Chiang, Yang-Cheng Lee, Ting-Tsung Chang, et al.
Nature Materials|September 15, 2022
Designed growth of large bilayer graphene with arbitrary twist anglesCan Liu, Zehui Li, Ruixi Qiao, et al.
Immunity|July 16, 2021
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinomaYang Cheng, Bavani Gunasegaran, Harsimran D Singh, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 11, 2023
Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in TaiwanMing-Ching Shen, Sheng-Chieh Chou, Shyh-Shin Chiou, et al.
Journal of Medicinal Chemistry|September 11, 2024
Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 MutationsTian-Hua Wei, Zi-Xuan Wang, Meng-Yi Lu, et al.
Cancer Discovery|September 14, 2023
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform TrialTina Cascone, Gozde Kar, Jonathan D Spicer, et al.
Bioorganic & Medicinal Chemistry|July 21, 2022
Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemiaJi-Bo Kang, Lu Chen, Xue-Jiao Leng, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 26, 2019
Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention of Recurrent Cardiovascular Events in a Real-World Cohort of Post-Acute Myocardial Infarction PatientsDuo Huang, Yang-Yang Cheng, Yiu-Tung Anthony Wong, et al.
ERJ Open Research|March 14, 2018
Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) studyDuo Huang, Yang-Yang Cheng, Pak-Hei Chan, et al.
Pageof 111